Cover Image
市場調查報告書

讀寫障礙:全球臨床實驗檢討

Dyslexia Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 235314
出版日期 內容資訊 英文 61 Pages
訂單完成後即時交付
價格
Back to Top
讀寫障礙:全球臨床實驗檢討 Dyslexia Global Clinical Trials Review, H1, 2015
出版日期: 2015年02月27日 內容資訊: 英文 61 Pages
簡介

本報告提供讀寫障礙的治療藥相關臨床實驗調查分析,提供您最新趨勢,各階段及Phase狀況,有潛力的企業,開發中的治療藥資訊,臨床實驗簡介等相關的系統性資訊。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中東·非洲的主要國家

G7各國的臨床實驗:中樞神經系統臨床實驗上讀寫障礙的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:各階段

各方面的臨床實驗

各階段臨床實驗

評估項目別臨床實驗

一定期間所採用的實驗對象

各類贊助商臨床實驗

有潛力的贊助商

  • 讀寫障礙治療藥臨床實驗的主要參與企業

有前途藥物

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Eli Lilly and Company
  • 主要大學·研究機關·醫院臨床實驗概要
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development
    • National Stroke Foundation
    • University of Tasmania
    • University of Munster
    • Rehabilitation Hospital of The Pacific
    • University of Oxford
    • Vanderbilt University
    • U.S. Department of Veterans Affairs
    • Rabin Medical Center

主要的臨床簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2573CTIDB

GlobalData's clinical trial report, "Dyslexia Global Clinical Trials Review, H1, 2015" provides data on the Dyslexia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dyslexia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Dyslexia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Dyslexia
    • Symptoms of dyslexia are:
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Dyslexia to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
    • Clinical Trial Overview of Top Institutes / Government
      • Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • National Stroke Foundation
      • Clinical Trial Overview of National Stroke Foundation
      • University of Tasmania
      • Clinical Trial Overview of University of Tasmania
      • University of Munster
      • Clinical Trial Overview of University of Munster
      • Rehabilitation Hospital of The Pacific
      • Clinical Trial Overview of Rehabilitation Hospital of The Pacific
      • University of Oxford
      • Clinical Trial Overview of University of Oxford
      • Vanderbilt University
      • Clinical Trial Overview of Vanderbilt University
      • U.S. Department of Veterans Affairs
      • Clinical Trial Overview of U.S. Department of Veterans Affairs
      • Rabin Medical Center
      • Clinical Trial Overview of Rabin Medical Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Dyslexia Therapeutics, Global, Clinical Trials by Region, 2015*
  • Dyslexia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Dyslexia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Dyslexia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Dyslexia Therapeutics Clinical Trials, Europe, Top Countries, 2015*
  • Dyslexia Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Dyslexia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Proportion of Dyslexia to Central Nervous System Clinical Trials, G7 Countries (%), 2015*
  • Dyslexia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Dyslexia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Dyslexia Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Dyslexia Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Dyslexia Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Dyslexia Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Dyslexia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Dyslexia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Dyslexia Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Dyslexia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015*
  • Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2015*
  • Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Stroke Foundation, 2015*
  • Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Tasmania, 2015*
  • Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Munster, 2015*
  • Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rehabilitation Hospital of The Pacific, 2015*
  • Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2015*
  • Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2015*
  • Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2015*
  • Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rabin Medical Center, 2015*

List of Figures

  • Dyslexia Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Dyslexia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Dyslexia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Dyslexia Therapeutics Clinical Trials, Europe, Top Countries (%), 2015*
  • Proportion of Dyslexia to Central Nervous System Clinical Trials, G7 Countries (%), 2015*
  • Dyslexia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Dyslexia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Dyslexia Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Dyslexia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Dyslexia Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Dyslexia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Dyslexia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Dyslexia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top